ImmuneXcite's Debt Round

ImmuneXcite raised a round of funding on December 13, 2011. Investors include Massachusetts Life Sciences Center.

ImmuneXcite has developed a platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets.…

Articles about ImmuneXcite's Debt Round: